Neuland Laboratories Ltd

NSE: NEULANDLAB · BSE: 524558 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹21,890.00
Market cap: ₹28,085 Cr
Revenue (annual): ₹2,023 Cr
Net profit (annual): ₹364.0 Cr
P/E (TTM): 56.4×Sector 50.4×
Promoter holding: 32.62%-0.01% QoQ
FII holding: 21.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Production Started 1 Capacity Expansion 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

15 Sep 2026 10:27 IST BSE

Production Started

Neuland Laboratories Production Started

Neuland commissioned its first commercial peptide manufacturing module with 7,000L reactor capacity. Module two expansion is underway to meet rising customer demand for peptide APIs.

peptide manufacturing reactor capacity: 7000 L

Read the filing ↗

7 Sep 2026 17:25 IST BSE

Capacity Expansion

Neuland Laboratories Capacity Expansion: ₹126 Cr Investment

Neuland Laboratories' board approved ₹126 Crore capex to acquire 134 acres of land in Andhra Pradesh for future expansion. The company holds ROFR on additional land.

Value: ₹126.0 Cr
land acquisition: 134.0 acres

Read the filing ↗